Simvastatin reduces myocardial infarct size via increased nitric oxide production in normocholesterolemic rabbits

Journal of Cardiology

Volumn 53, Issue 1, 2009, Pages 102-107

  Bao, Narentuoya ^a   Ushikoshi, Hiroaki ^a   Kobayashi, Hiroyuki ^a   Yasuda, Shinji ^a   Kawamura, Itta ^a   Iwasa, Masamitsu ^a   Yamaki, Takahiko ^a   Sumi, Shohei ^a   Nagashima, Kenshi ^a   Aoyama, Takuma ^a   Kawasaki, Masanori ^a   Nishigaki, Kazuhiko ^a   Takemura, Genzou ^a   Minatoguchi, Shinya ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Infarct size; Nitric oxide; Simvastatin

Indexed keywords

N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; SIMVASTATIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY RISK; EXPERIMENTAL RABBIT; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART WEIGHT; HEMODYNAMIC PARAMETERS; MALE; NONHUMAN; TREATMENT OUTCOME;

ANIMALS; CHOLESTEROL; CORONARY VESSELS; ENZYME INHIBITORS; HEART; HEMODYNAMICS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MYOCARDIAL INFARCTION; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; ORGAN SIZE; RABBITS; SIMVASTATIN;

EID: 58249129963     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2008.09.012     Document Type: Article

References (24)

1. Shepherd J. The West of Scotland Coronary Prevention Study: a trial of cholesterol reduction in Scottish men. Am J Cardiol 76 (1995) 113C-117C
2. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344 (1994) 1383-1389
3. Takemoto M., and Liao J.K. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Arterioscler Thromb Vasc Biol 21 (2001) 1712-1719
4. Wayman N.S., Ellis B.L., and Thiemermann C. Simvastatin reduces infarct size in a model of acute myocardial ischemia and reperfusion in the rat. Med Sci Monit 9 (2003) BR155-BR159
5. Matsuki A., Igawa A., Nozawa T., Nakadate T., Igarashi N., Nonomura M., et al. Early administration of fluvastatin, but not at the onset of ischemia or reperfusion, attenuates myocardial ischemia-reperfusion injury through the nitric oxide pathway rather than its antioxidant property. Circ J 70 (2006) 1643-1649
6. Lebuffe G., Schumacker P.T., Shao Z.H., Anderson T., Iwase H., and Vanden Hoek T.L. ROS and NO trigger early preconditioning: relationship to mitochondrial KATP channel. Am J Physiol Heart Circ Physiol 284 (2003) H299-H308
7. Minatoguchi S., Arai M., Uno Y., Kariya T., Nishida Y., Hashimoto K., et al. A novel anti-diabetic drug, miglitol, markedly reduces myocardial infarct size in rabbits. Br J Pharmacol 128 (1999) 1667-1672
8. Lefer A.M., Campbell B., Shin Y.K., Scalia R., Hayward R., and Lefer D.J. Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts. Circulation 100 (1999) 178-184
9. Jones S.P., Trocha S.D., and Lefer D.J. Pretreatment with simvastatin attenuates myocardial dysfunction after ischemia and chronic reperfusion. Arterioscler Thromb Vasc Biol 21 (2001) 2059-2064
10. Bao N., Minatoguchi S., Kobayashi H., Yasuda S., Kawamura I., Iwasa M., et al. Pravastatin reduces myocardial infarct size via increasing protein kinase C-dependent nitric oxide, decreasing oxyradicals and opening the mitochondrial adenosine triphosphate-sensitive potassium channels in rabbits. Circ J 71 (2007) 1622-1628
11. Wolfrum S., Grimm M., Heidbreder M., Dendorfer A., Katus H.A., Liao J.K., et al. Acute reduction of myocardial infarct size by a hydroxymethyl glutaryl coenzyme A reductase inhibitor is mediated by endothelial nitric oxide synthase. J Cardiovasc Pharmacol 41 (2003) 474-480
12. Yamakuchi M., Greer J.J., Cameron S.J., Matsushita K., Morrell C.N., Talbot-Fox K., et al. HMG-CoA reductase inhibitors inhibit endothelial exocytosis and decrease myocardial infarct size. Circ Res 96 (2005) 1185-1192
13. Kitakaze M., Node K., Minamino T., Asanuma H., Kuzuya T., and Hori M. A Ca channel blocker, benidipine, increases coronary blood flow and attenuates the severity of myocardial ischemia via NO-dependent mechanisms in dogs. J Am Coll Cardiol 33 (1999) 242-249
14. Tsao P.S., McEvoy L.M., Drexler H., Butcher E.C., and Cooke J.P. Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by l-arginine. Circulation 89 (1994) 2176-2182
15. Furlong B., Henderson A.H., Lewis M.J., and Smith J.A. Endothelium-derived relaxing factor inhibits in vitro platelet aggregation. Br J Pharmacol 90 (1987) 687-692
16. Sneddon J.M., and Vane J.R. Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells. Proc Natl Acad Sci USA 85 (1988) 2800-2804
17. Mollace V., Salvemini D., Anggard E., and Vane J. Nitric oxide from vascular smooth muscle cells: regulation of platelet reactivity and smooth muscle cell guanylate cyclase. Br J Pharmacol 104 (1991) 633-638
18. Wright C.D., Mulsch A., Busse R., and Osswald H. Generation of nitric oxide by human neutrophils. Biochem Biophys Res Commun 160 (1989) 813-819
19. Cohen R.A., and Weisbrod R.M. Endothelium inhibits norepinephrine release from adrenergic nerves of rabbit carotid artery. Am J Physiol 254 (1988) H871-H878
20. Wang N., Minatoguchi S., Chen X.H., Arai M., Uno Y., Lu C., et al. Benidipine reduces myocardial infarct size involving reduction of hydroxyl radicals and production of protein kinase C-dependent nitric oxide in rabbits. J Cardiovasc Pharmacol 43 (2004) 747-757
21. Takano H., Manchikalapudi S., Tang X.L., Qiu Y., Rizvi A., Jadoon A.K., et al. Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits. Circulation 98 (1998) 441-449
22. Weiss H.R., Sadoff J.D., Scholz P.M., and Klabunde R.E. Nitric oxide reduces myocardial contractility in isoproterenol-stimulated rat hearts by a mechanism independent of cyclic GMP or cyclic AMP. Pharmacology 55 (1997) 202-210
23. Stangl V., Baumann G., Stangl K., and Felix S.B. Negative inotropic mediators released from the heart after myocardial ischaemia-reperfusion. Cardiovasc Res 53 (2002) 12-30
24. Inoue M., Sato E.F., Park A.M., Nishikawa M., Kasahara E., Miyoshi M., et al. Cross-talk between NO and oxyradicals, a supersystem that regulates energy metabolism and survival of animals. Free Radic Res 33 (2000) 757-770